May 23, 2013

10:00p
Biogen Submits Plegridy BLA - Analyst Blog   (Zacks.com)
8:00a
Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer   (Business Wire)
7:15a
Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML)   (PR NewsWire)

May 22, 2013

8:25p
Additional Patent for Acorda's Ampyra - Analyst Blog   (Zacks.com)
4:01p
Biogen Idec to Present at the Deutsche Bank 38th Annual dbAccess Healthcare Conference   (Business Wire)

May 21, 2013

9:40p
Positive Data on Novo Nordisk's N9-GP - Analyst Blog   (Zacks.com)
4:30a
Biogen Idec Submits Application to FDA for Approval of PLEGRIDY(TM) (Peginterferon Beta-1a) in Multiple Sclerosis   (Business Wire)

May 20, 2013

3:10p
Biogen's Hemophilia BLA Accepted - Analyst Blog   (Zacks.com)

May 16, 2013

10:29a
Biogen Idec Foundation Awards $250,000 to East End House to Develop Genetics Education Program   (Business Wire)

May 14, 2013

3:56p
Isis Gets $3.5M Milestone Payment - Analyst Blog   (Zacks.com)

May 13, 2013

7:30a
FDA Accepts Biogen Idec's Biologics License Application for First Long-Lasting Factor VIII Therapy for Hemophilia A   (Business Wire)

May 9, 2013

4:34p
Isis Pharmaceuticals Earns $3.5 Million from Biogen Idec   (PR NewsWire)
12:15p
UPDATE 1: Why I stopped using stop loss orders   (MarketWatch)
8:35a
Why I stopped using stop loss orders   (MarketWatch)

May 8, 2013

9:43a
Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog   (Zacks.com)

May 6, 2013

4:40p
Bayer Discontinues Hemophilia Study - Analyst Blog   (Zacks.com)
2:30p
Acorda Incurs Loss, Maintains Guidance - Analyst Blog   (Zacks.com)

May 1, 2013

8:33a
US markets headed for an unexciting morning   (InvestorsKeyhole, various news and data sources)

April 30, 2013

9:31a
Critical Alerts For IBM, Biogen Idec, St. Jude Medical, NII Holdings, and Arcos Dorados Released By InvestorsObserver   (PR NewsWire)
6:30a
INTERPHEX 2013: It's a Wrap on Pharma's Biggest Conference of the Year, an Industrial Info News Alert   (Market Wire)

April 29, 2013

10:23a
Stocks higher after Italy forms coalition government   (InvestorsKeyhole, various news and data sources)

April 26, 2013

8:05a
Biotech's latest rally: exuberance or execution?   (MarketWatch)

April 25, 2013

5:30p
Acorda Initiates Study on rHIgM22 - Analyst Blog   (Zacks.com)
4:25p
UPDATE 3: Thursday's movers: Tesla pops on Musk tweet   (MarketWatch)
12:26p
S&P MAINTAINS HOLD OPINION ON SHARES OF BIOGEN IDEC   (S&P Capital IQ)
12:09p
Elan Narrows Y/Y Loss - Analyst Blog   (Zacks.com)
11:30a
Biogen's Earnings Surpass Expectations - Analyst Blog   (Zacks.com)
8:59a
Thursday movers: Akamai, Cliffs Natural Resources   (MarketWatch)
6:36a
Biogen Idec Total Revenues Increased 10% to $1.4 Billion in First Quarter 2013   (Business Wire)

April 24, 2013

5:10p
Isis Pharma's ISIS-SMNRx Progresses - Analyst Blog   (Zacks.com)

April 23, 2013

1:40p
S&P MAINTAINS HOLD OPINION ON SHARES OF BIOGEN IDEC   (S&P Capital IQ)
7:00a
ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy   (PR NewsWire)

April 22, 2013

4:51p
UPDATE 6: Monday's movers: Apple rallies ahead of earnings   (MarketWatch)
4:47p
UPDATE 5: Monday's movers: Apple rallies ahead of earnings   (MarketWatch)
4:42p
UPDATE 4: Monday's movers: Apple rallies ahead of earnings   (MarketWatch)
Go to All Current & Historical News